ArticlemedRxiv : the preprint server for health sciences2025
Characterization of shared and ancestry-specific signals driving complex traits using multi-ancestry fine-mapping.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
While most signals identified by genome-wide association studies (GWAS) are shared across populations, the growing size and diversity of GWAS datasets provides evidence that a subset of signals are ancestry-specific. Yet, characterizing these signals remains challenging, since the underlying causal variants are often unknown. Statistical fine-mapping aims to identify candidate causal variants, but struggles to distinguish between variants in high linkage disequilibrium (LD). Multi-study fine-mapping methods can improve resolution by leveraging population-specific LD patterns, but typically assume causal variants are shared and/or polymorphic across studies, making it challenging to study ancestry-specific contributions. To overcome these limitations, we introduce PIPSORT, a multi-study fine-mapping method which simultaneously detects both shared and ancestry-specific signals and quantifies evidence of signal sharing across studies. We applied PIPSORT to fine-map platelet count and LDL cholesterol (LDL-C) in individuals of primarily African vs. European ancestry in the UK Biobank (UKB) and
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.